No company could recommend/add PAB to their list with 2 failed GMP runs and a delay in their 3rd it would not look well for them, however if this GMP is a success then many more will be adding PAB to their list to promote..
Around 50% decline for failure and 2-300% slow rise to clinic on a positive is just not bringing anyone in for the gamble, even if we succeed the "sporodic"" event is still in peoples minds....
Also with a delay to the clinic until next year highly likely with a delayed GMP result(if positive) means traders will bring this up and down for many months ahead..
Short term, even with good results only positive left field Ann's is our only hope for multiple gains
Ann: Further update on PAT-DX1 GMP manufacturing run, page-41
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.6¢ |
Change
-0.001(14.3%) |
Mkt cap ! $12.34M | |||
| Open | High | Low | Value | Volume |
| 0.6¢ | 0.6¢ | 0.6¢ | $4.61K | 768.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 728075 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 3743101 | 5 |
View Market Depth
| Last trade - 15.05pm 12/08/2024 (20 minute delay) ? |
| PAB (ASX) Chart |